Webinar
The Preclinical Arbitrage: Why Early Biotech Is Mispriced. For Now.
Join Luca Giani, Senior Principal at Alumni Ventures, for an introduction to Alumni Ventures and a clear-eyed look at how individual accredited investors can access institutional-quality venture capital — once an asset class reserved almost entirely for endowments, pensions, and family offices.
In this session, Luca Giani, Senior Principal at Alumni Ventures, will introduce Alumni Ventures and walk through how the firm has built a venture platform designed specifically for individual accredited investors. Luca will cover what Alumni Ventures invests in, how its diversified fund and syndicate offerings are structured, and what sets the firm apart as one of the most active venture investors in the country.
The conversation will go beyond a firm overview to explore why venture capital has become an increasingly important component of sophisticated portfolios — from the endowment-style allocation model to why companies are staying private longer than ever. Luca will discuss how Alumni Ventures’ approach to diversification, manager-led investing, and access to high-quality deal flow is built to give individual investors a venture experience that closely mirrors what institutions have enjoyed for decades.
Whether you’re new to venture, evaluating Alumni Ventures for the first time, or already familiar with the firm and looking to deepen your understanding, this session will give you a clear, jargon-free foundation. Register to walk away with a confident view of how Alumni Ventures works, how its funds and syndicates are constructed, and how venture capital can fit into a long-term investment strategy.
Want to access our The Yard Syndicate deals to see, evaluate, and optionally invest? No cost, no commitment.
Why Attend?
- HomeDiscover how Alumni Ventures has built a venture platform designed specifically for individual accredited investors
- HomeUnderstand the structural shifts — companies staying private longer, endowment-style allocation, expanded access — that have made venture a more important part of sophisticated portfolios
- HomeLearn how Alumni Ventures' funds and syndicates are constructed, and how to think about venture as a long-term portfolio decision
Rated a Top 20 VC Firm by both TIME and CB Insights.
Alumni Ventures is America’s largest venture capital firm for individual investors.
About your presenter
Senior Principal
Luca Giani is a Senior Principal, investor, and serial entrepreneur with a track record across venture creation, M&A, and translational science. He specializes in bridging science, strategy, capital, and talent to help build mission-driven ventures.
Luca was the Founder & CEO of Ilios Therapeutics, a neuroscience company developing a novel chemistry platform to address ALS, Parkinson’s, and Alzheimer’s disease. Under his leadership, Ilios built a diversified preclinical pipeline, advanced lead optimization, filed foundational IP, and positioned the company for strategic partnerships.
Luca is a Termeer Fellow, part of a global network of emerging biotech CEOs mentored by industry leaders. He previously served as a Blavatnik Fellow in Life Science Entrepreneurship at Harvard Business School, and as a Technology and Public Purpose Fellow at Harvard’s Belfer Center, appointed by and working with former U.S. Secretary of Defense Ash Carter, where he authored policy work on accelerating treatments for neurodegenerative diseases under the mentorship of Dr. Robert Langer.
Earlier in his career, Luca co-founded Innbiotec Pharma; led international investments in MedTech and digital health at 5Lion Ventures; and co-founded and commercialized Somnifix, a patented sleep apnea and snoring therapy. He began his career in M&A at Credit Suisse, followed by strategy consulting at Bain & Company in London, advising clients on market expansion, transformation, and operational optimization.
Luca holds a Master with Distinction from Harvard, has completed programs at Harvard Medical School, Harvard Business School, and MIT Sloan, and earned his B.S. magna cum laude from Georgetown University.